Loyola University
Trial Pipeline
Multisensory Early Oral Administration of Human Milk (M-MILK) for Very Preterm Infants
NCT07216664
RCT Glargine vs NPH for Treatment of DM in Pregnancy
NCT06619301
Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer
NCT05983276
The Impact of a Race-Based Stress Reduction Intervention
NCT05902741
IPACK on Early Pain Scores After ACL Reconstruction
NCT05985629
Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients
NCT05554068
Buprenorphine, Clonidine, and Dexamethasone on Duration of Brachial Plexus Blocks for Upper Extremity Surgery
NCT05824832
Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors
NCT05728957
Musculoskeletal and Pelvic Floor Health in Female Chronic Overlapping Pelvic Pain Conditions
NCT05750212
Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks
NCT05557279
Ketamine as a Supplement to Local Anesthesia for Minor Procedures
NCT06284473
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
NCT02870244
Effect of Standardization of Urine Collection Using PEEZY Device as Compared to Clean Peezy for DAB
NCT05554081
CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell Malignancies
NCT04214886
Gut Microbiota, Short Chain Fatty Acids, and Adiposity Across The Epidemiological Transition
NCT03378765
Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy
NCT03312972
Transfer of Genetically Engineered Lymphocytes in Melanoma Patients
NCT01586403
Surgeon Core-strengthening Program as a Modifier for Exertion Associated With Vaginal Surgery
NCT06525701
Restoring the Anatomic Tension Relationship of the Long Head of the Biceps During Tenodesis
NCT06571695
Photographic Evidence on Total Knee Arthroplasty Outcomes
NCT07223359
The Role of Antimicrobial Foam Dressing in Prevention of Cesarean Section Wound Complications
NCT03136159
Port Size and Post-Operative Pain Perception by Patients
NCT02521987
Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D)
NCT02186015
Sunshine 2 Study for Women With Diabetes
NCT01904032
Bacterial Genomic Sequencing in Overactive Bladder
NCT01642277
Abdominal Colpopexy: Comparison of Endoscopic Surgical Strategies
NCT01124916
Vitamin D for Improving Metabolic Control and Depressive Symptoms
NCT01185574
Bladder Drainage During Labor: A Randomized Controlled Study of Obstetric Foley Therapy
NCT00959920
Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency
NCT00911625
Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer
NCT00756717
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 5 |
| Phase 3 | 1 |
| Phase 4 | 6 |
What the Pipeline for Loyola University Shows
According to the ClinicalTrials.gov registry, Loyola University is linked to 57 US clinical trials across every stage of research activity. Of those, 39 studies are currently recruiting — about 68% of the sponsor's indexed portfolio — and 13 are already marked complete, representing roughly 23% of the total. Recruiting share is one of the more practical signals here: it reflects how much of a sponsor's research is presently open to new participants, while the completed share indicates the depth of finished work that has already contributed registry results. Both counts come directly from the public ClinicalTrials.gov dataset and are refreshed on the registry side; this page mirrors the latest data pull without altering it.
The phase mix for Loyola University reports 7 late-stage studies (Phase 3 and Phase 4 combined) and 8 earlier-phase studies (Phase 1 and Phase 2). A portfolio weighted toward Phase 3 usually reflects an organization advancing candidates toward regulatory review, where the research centers on comparative efficacy and broader safety across larger populations. A heavier Phase 1 and Phase 2 tilt generally indicates exploratory work — safety, dosing, and early signal detection — and is common among research-forward sponsors that seed many early programs. Phase 4 entries, when present, track interventions already in real-world use and typically focus on long-term safety, effectiveness across subgroups, or formulation comparisons.
The top therapeutic focus area indexed for Loyola University is Diabetes with 3 linked trials, and 9 other condition areas appear in the top list above. That distribution is a quick read of where the organization concentrates its research attention; it does not imply product availability, market share, or any clinical endorsement. All numbers on this page come from ClinicalTrials.gov maintained by the National Library of Medicine, and counts can shift as new studies are registered or existing ones update their status. This information is provided for reference and educational purposes only, not as medical, investment, or regulatory advice — verify current details directly with ClinicalTrials.gov before relying on any figure here.
Read our methodology — how this data is sourced, computed, and verified.